Volume 12, Number 4—April 2006
Research
Identifying Influenza Viruses with Resequencing Microarrays
Zheng Wang*†, Luke T. Daum‡, Gary J. Vora*, David Metzgar§, Elizabeth A. Walter¶, Linda C. Canas‡, Anthony P. Malanoski*, Baochuan Lin*, and David A. Stenger*
Table 4
Strain component analysis of the FluMist vaccine with respiratory pathogen microarray (RPM) version 1*
| Segment | Base call rate† (%) | Strain identification | GenBank accession no. |
|---|---|---|---|
| A/HA1 | 86.8 | A/New Caledonia/20/99 | AJ344014 |
| A/NA1 | 65.6 | A/New Caledonia/20/99 | AJ518092 |
| A/HA3 | 86.5 | A/Wyoming/3/03 | AY531033 |
| A/NA2 | 78.2 | A/Wyoming/3/03 | AY531034 |
| A/M | 75.9 | A/Ann Arbor/6/60 | M23978 |
| B/HA | 77.1 | B/Jilin/20/2003 | ISDN40908 |
| B/NA | 83.5 | B/Yamagata/1246/2003‡ | AB120256 |
| B/M | 78.4 | B/Ann Arbor/1/66 | M20175 |
*HA, hemagglutinin; NA, neuramindase; M, matrix.
†No. of base calls generated from the RPM version 1 divided by the length of the tiled probe sequence.
‡The NA sequence of B/Jilin/20/2003 strain was not available in the influenza database.
Page created: January 24, 2012
Page updated: January 24, 2012
Page reviewed: January 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.